In pharmaceutical manufacturing, tools play a crucial role in the final output. After all, these tools are made to ensure precise and consistent measurements for each product. As pharmaceutical companies discover new ways to create more potent medications and supplements, manufacturers reinforce their facilities with new tools such as the Xcelodose system.

In the pharmaceutical industry, many companies implement direct-API-in-capsule projects that eliminate the need for excipient compatibility and pre-formulation activities. This, in turn, drastically cuts down on first-to-human and first-to-market times, which matter greatly in the competitive market.

While older encapsulating systems aren’t able to handle API, the newer Xcelodose system allows manufacturers to carry out direct-API-in-capsule projects. On top of that, the system also allows precision micro-dosage at as low as 100ug per capsule. The high precision the Xcelodose system is capable of assures pharmaceutical companies of a quality product made to their specifications.

But handing a direct-API-in-capsule project isn’t simply about utilizing the Xcelodose system. Active ingredients may be sensitive to various factors, including humidity and temperature. Given this, humidity control units are also important for pharmacists looking to pursue direct-API-in-capsule projects. When paired with the Xcelodose system, it is possible to process challenging compounds that are prone to static, or are poorly flowing or hygroscopic.

As precision pharmaceutical manufacturing entails a great amount of equipment, pharmaceutical companies will need the help of qualified contract manufacturers. Given their focus on manufacturing, they will have the most updated resources, which may include the latest Xcelodose system or a dedicated facility for direct-API-in-capsule projects.

Competitive contract pharmaceutical manufacturers, such as UPM Pharmaceuticals, will often go beyond simply carrying the latest Xcelodose system. These manufacturers would also provide outstanding delivery times and pay close attention to detail, whether for commercial or academic projects.

By outsourcing the manufacturing process to these firms, pharmaceutical companies can take advantage of the most up-to-date facilities available while simultaneously avoiding the cost of in-house drug production.